170 related articles for article (PubMed ID: 30471702)
1. Challenges in the Structural-Functional Characterization of Multidomain, Partially Disordered Proteins CBP and p300: Preparing Native Proteins and Developing Nanobody Tools.
Bekesi A; Abdellaoui S; Holroyd N; Van Delm W; Pardon E; Pauwels J; Gevaert K; Steyaert J; Derveaux S; Borysik A; Tompa P
Methods Enzymol; 2018; 611():607-675. PubMed ID: 30471702
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
3. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
Dyson HJ; Wright PE
J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
[TBL] [Abstract][Full Text] [Related]
4. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
[TBL] [Abstract][Full Text] [Related]
5. Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.
Contreras-Martos S; Piai A; Kosol S; Varadi M; Bekesi A; Lebrun P; Volkov AN; Gevaert K; Pierattelli R; Felli IC; Tompa P
Sci Rep; 2017 Jul; 7(1):4676. PubMed ID: 28680062
[TBL] [Abstract][Full Text] [Related]
6. E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300.
Hyndman BD; Thompson P; Bayly R; Côté GP; LeBrun DP
Biochim Biophys Acta; 2012 May; 1819(5):446-53. PubMed ID: 22387215
[TBL] [Abstract][Full Text] [Related]
7. Modulating the masters: chemical tools to dissect CBP and p300 function.
Breen ME; Mapp AK
Curr Opin Chem Biol; 2018 Aug; 45():195-203. PubMed ID: 30025258
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclic adenosine monophosphate response element binding protein on renin expression in kidney via complex cyclic adenosine monophosphate response element-binding-protein-binding protein/P300 recruitment.
Li P; Zhang J; Zhu Y; Liu M; Xuan J
Iran J Kidney Dis; 2015 Nov; 9(6):440-8. PubMed ID: 26552350
[TBL] [Abstract][Full Text] [Related]
9. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
[TBL] [Abstract][Full Text] [Related]
10. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
Ogiwara H; Sasaki M; Mitachi T; Oike T; Higuchi S; Tominaga Y; Kohno T
Cancer Discov; 2016 Apr; 6(4):430-45. PubMed ID: 26603525
[TBL] [Abstract][Full Text] [Related]
11. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.
Kasper LH; Fukuyama T; Lerach S; Chang Y; Xu W; Wu S; Boyd KL; Brindle PK
PLoS One; 2013; 8(12):e82684. PubMed ID: 24340053
[TBL] [Abstract][Full Text] [Related]
12. Differential role for CBP and p300 CREB-binding domain in motor skill learning.
Oliveira AM; Abel T; Brindle PK; Wood MA
Behav Neurosci; 2006 Jun; 120(3):724-9. PubMed ID: 16768624
[TBL] [Abstract][Full Text] [Related]
13. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.
Frangioni JV; LaRiccia LM; Cantley LC; Montminy MR
Nat Biotechnol; 2000 Oct; 18(10):1080-5. PubMed ID: 11017047
[TBL] [Abstract][Full Text] [Related]
14. Systematic in vivo structure-function analysis of p300 in hematopoiesis.
Kimbrel EA; Lemieux ME; Xia X; Davis TN; Rebel VI; Kung AL
Blood; 2009 Nov; 114(23):4804-12. PubMed ID: 19822904
[TBL] [Abstract][Full Text] [Related]
15. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis.
Kasper LH; Boussouar F; Ney PA; Jackson CW; Rehg J; van Deursen JM; Brindle PK
Nature; 2002 Oct; 419(6908):738-43. PubMed ID: 12384703
[TBL] [Abstract][Full Text] [Related]
16. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
17. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
18. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral E1A Exploits Flexibility and Disorder to Target Cellular Proteins.
Murrali MG; Felli IC; Pierattelli R
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33187345
[TBL] [Abstract][Full Text] [Related]
20. CBP/p300 acetyltransferase activity in hematologic malignancies.
Dutta R; Tiu B; Sakamoto KM
Mol Genet Metab; 2016 Sep; 119(1-2):37-43. PubMed ID: 27380996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
